Inventor · disambiguated record
Maria Vilenchik
Also filed as: VILENCHIK MARIA
8 granted patents·5 pending applications·22 citations·filing 1992–2022
83Inventor score
Top patents by PatentIndex Score
13 records- 0177US10322128B2Combinations for the treatment of neoplasms using quiescent cell targeting with EGFR inhibitorsFELICITEX THERAPEUTICS INC·Filed 2017·Granted Jun 18, 2019·3 cites·20 claims
- 0274US10314843B2Combinations for the treatment of neoplasms using quiescent cell targeting and inhibitors of mitosisFELICITEX THERAPEUTICS INC·Filed 2017·Granted Jun 11, 2019·2 cites·20 claims
- 0371US11202779B2Combinations for the treatment of neoplasms using quiescent cell targeting with EGFR inhibitorsFELICITEX THERAPEUTICS INC·Filed 2019·Granted Dec 21, 2021·1 cites·9 claims
- 0465US2022110940A1Combinations for the treatment of neoplasms using quiescent cell targeting with egfr inhibitorsFELICITEX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0565US2022110941A1Combinations for the treatment of neoplasms using quiescent cell targeting and inhibitors of mitosisFELICITEX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0657US10577365B2Derivatives of quinoline as inhibitors of DYRK1A and/or DYRK1B kinasesFELICITEX THERAPEUTICS INC·Filed 2017·Granted Mar 3, 2020·1 cites·14 claims
- 0753US2019290651A1Combinations for the treatment of neoplasms using quiescent cell targeting and inhibitors of mitosisFELICITEX THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0850US2023226061A1Combination cancer therapy with dyrk1 inhibitors and inhibitors of the ras-raf-mek-erk (mapk) pathwayFELICITEX THERAPUETICS INC·Filed 2022·Application pending·0 cites
- 0943US5627277AMethod for analyzing oligonucleotide analogsHYBRIDON INC·Filed 1994·Granted May 6, 1997·5 cites·25 claims
- 1041US5643717ASubstrate useful for separating modified oligonucleotidesHYBRIDON INC·Filed 1993·Granted Jul 1, 1997·3 cites·11 claims
- 1140US5420265ASeparation of phosphorothioate oligonucleotides by capillary gel electrophoresisHYBRIDON INC·Filed 1992·Granted May 30, 1995·3 cites·12 claims
- 1239US2015292032A1Treatment of cancer by targeting quiescent cancer cellsFELICITEX THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 1335US5637464AMethod of detecting sub-ppb levels of oligonucleotides in biological fluidsHYBRIDON INC·Filed 1995·Granted Jun 10, 1997·4 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Maria Vilenchik files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →